TMSH (TransGlobal Assets) Cash Ratio: 0.00 (As of Dec. 2011)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is TransGlobal Assets Cash Ratio?

TransGlobal Assets TMSH Cash Ratio is 0.00 as of Dec. 2011.

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. TransGlobal Assets's Cash Ratio for the quarter that ended in Dec. 2011 was 0.00.

TransGlobal Assets has a Cash Ratio of 0.00. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for TransGlobal Assets's Cash Ratio or its related term are showing as below:

TMSH's Cash Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.61
* Ranked among companies with meaningful Cash Ratio only.

TransGlobal Assets  (OTCPK:TMSH) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


TransGlobal Assets Cash Ratio Related Terms


TransGlobal Assets Cash Ratio Historical Data

* Premium members only.

The historical data trend for TransGlobal Assets's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TransGlobal Assets Cash Ratio Chart

TransGlobal Assets Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Cash Ratio
0.00 0.00 0.00 0.00 0.00

TransGlobal Assets Semi-Annual Data
Dec07 Dec08 Dec09 Dec10 Dec11
Cash Ratio 0.00 0.00 0.00 0.00 0.00

TMSH vs CLDOF: Cash Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TransGlobal Assets's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TransGlobal Assets Cash Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TransGlobal Assets's Cash Ratio distribution charts can be found below:

* The bar in red indicates where TransGlobal Assets's Cash Ratio falls into.



TransGlobal Assets Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

TransGlobal Assets's Cash Ratio for the fiscal year that ended in Dec. 2011 is calculated as:

TransGlobal Assets's Cash Ratio for the quarter that ended in Dec. 2011 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Ratio →
What does a Cash Ratio of 0.00 mean?
TransGlobal Assets (TMSH) has a Cash Ratio of 0.00 as of Dec. 2011. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on TransGlobal Assets and its competitors.
Is TransGlobal Assets' Cash Ratio too high?
TransGlobal Assets' current Cash Ratio is 0.00.
How does TransGlobal Assets' Cash Ratio compare to CLDOF?
TransGlobal Assets' Cash Ratio of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median Cash Ratio is 0.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.61, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on TransGlobal Assets and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TransGlobal Assets's current Cash Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransGlobal Assets stock overvalued right now?
TransGlobal Assets (TMSH) has a current Cash Ratio of 0.00. The current Cash Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For TransGlobal Assets (TMSH), the current Cash Ratio is 0.00 as of Dec. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TransGlobal Assets Business Description

Address No. 14, 5555 Sagamore Avenue, Portsmouth, NH, USA, 03801
TransGlobal Assets Inc through its subsidiary Mindwell Solutions Group LLC (MWSG), the company develops proprietary solutions that harness AI, biometric analysis, and behavioral data to address high-growth markets, including mental health, relationship wellness, performance analytics, and sports/entertainment. and also offers a pioneer in transforming the health and wellness industries through cutting-edge products and services. The products and services are focused on being at the forefront of the health and wellness sectors, developing technologies and solutions that are driving industry growth and transforming lives. The portfolio includes a range- of-products and services, from telemedicine platforms to wellness retreats and natural health remedies.